Honestly, Eli Lilly hitting $1 trillion just on a couple of GLP-1 drugs is wild. Mounjaro and Zepbound are obviously selling like crazy for diabetes and weight loss… but come on, let’s not forget the **real game-changers** in pharma:
**=> Roche**: *Ocrevus* has slowed MS progression for thousands of people; *Tecentriq* has actually extended lives in advanced lung and bladder cancer; *Hemlibra* turned hemophilia from a life-threatening disease into something people can manage.
=> **Novartis**: *Kymriah* CAR-T therapy can literally cure certain leukemias in one shot; *Entresto* helps heart failure patients live longer; *Cosentyx* completely changed life for people with severe psoriasis.
These are **life-saving, life-changing drugs**, backed by decades of R&D and billions of dollars in investment. And yet, Roche and Novartis aren’t even close to a trillion-dollar market cap… while Lilly, riding the hype of a couple of trendy weight-loss drugs, suddenly hits the club. It just shows how the market today rewards **short-term hype and huge sales potential**, not the drugs that actually make a lasting impact on people’s lives.
**The algos are buying US stocks in bulk because the money comes from the US. That’s it.**
Tom "fat cuck" Lee fell so hard he's selling investment courses now 🤡😂🤌
https://x.com/fundstrat/status/1991954863492841518?t=WWg97Q2TRSOHiWkv20JqiA&s=19
NVDA will test 183 on Monday in an optimistic scenario. Best case is 185 on Tuesday. That is just what I'm seeing in the charts.
Might also try META 625 C exp 11/28 if it breaks 600. Just some ideas.
[https://x.com/KinggTrades/status/1991978847101940017?t=cTYtmP1D7LYGijd57uEfAA&s=19](https://x.com/KinggTrades/status/1991978847101940017?t=cTYtmP1D7LYGijd57uEfAA&s=19) Stole the image from this tweet lmfao
Bro, fintwit is stealing your shit. [Assholes.](https://x.com/KinggTrades/status/1991978847101940017?t=cTYtmP1D7LYGijd57uEfAA&s=19)
Edit: nvm, you ripping their shit.